博尔哈维亚扩散L.: 综合传统用途,植物化学,药理性质和质量控制/质量保证
Sunil Kumar1, Bikarma Singh2,3
1Department of Chemistry, Sant Kavi Baba Baijnath, Govt P.G. College, Barabanki, India.
Chemistry & biodiversity
|December 8, 2025
概括
传统草药Buerhavia diffusa含有132种具有抗氧化和抗炎功能的植物化学物质,验证了其药用. 由于过度开采,保护工作至关重要.
科学领域:
- 民族植物学和植物化学.
- 药理学和分析化学 分析化学
背景情况:
- 博尔哈维亚扩散植物 (Boerhavia diffusa L.) 是一种传统的药用草本,用于治疗肝脏,脏,心血管和尿路问题.
- 它的治疗潜力在现代科学研究中越来越被认可.
- 本综述侧重于其传统用途,化学成分,药理作用和标准化方法.
研究的目的:
- 审查 Boerhavia diffusa. 的传统用途,植物化学物质和药理学影响.
- 探索用于标准化草药配方的分析方法.
- 评估草药的药用价值,并指导未来的研究和保护.
主要方法:
- 从1979年到2025年使用像PubMed和Google Scholar这样的数据库进行系统的文献审查.
- 植物化学品及其属性的识别.
- 分析用于标准化的先进技术 (HPTLC,HPLC,GC-MS).
主要成果:
- 在B. diffusa中鉴定出132种植物化学物质,包括轮类,黄类,类和类.
- 许多化合物表现出抗氧化,抗炎和抗菌活性.
- 分析方法确认生物活性标记物用于质量控制,验证传统用途.
结论:
- 博尔哈维亚扩散植物具有显著的治疗价值,其植物化学特征和传统应用得到了支持.
- 需要进一步的研究来阐明分子机制,并探索充分的药理潜力.
- 由于过度开发和野生种群减少,建议保护和社区种植.
相关概念视频
01:09Bioequivalence of Drugs: Drugs with Multiple Indications
141
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
141
01:19Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
157
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
157
01:29Clinically Relevant Drug Product Specifications: Methods of Establishment
186
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
186
01:13Bioequivalence studies: Biowaivers
210
Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
210
01:16Bioequivalence: Overview
1.6K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.6K
01:28Biopharmaceutics and Pharmacokinetics: Overview
3.2K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
3.2K